2020 International Symposium on Respiratory Medicine II
Time：2020/ 05 /23、24 09:00~17:00
Location：Taipei Medicine University
Prof. Kian Fan CHUNG
National Heart & Lung Institute Imperial College London
The mechanisms of Airway wall remodeling in asthma
Prof. ICHINOSE Masakazu
Tohoku University Tohokudai · Department of Respiratory Medicine
Role of reactive persulfides in COPD
Prof. Kazuhiro Ito
Faculty of Medicine, National Heart & Lung Institute
Synergy of ambient particular matter and infections in airway remodeling in COPD
Prof. Ian Alcock
Faculty of Medicine, National Heart & Lung Institute Professor of Respiratory Cell & Molecular Biology
The role of mitochondrial dysfunction in COPD
Prof. Kittipong Maneechotesuwan
Faculty of Medicine Siriraj Hospital, Mahidol University
Role of TGF-beta and TGF-beta-activating kinase 1 (TAK 1) in asthma with fixed airway obstruction
Prof. Takashi Yoshiyama
Management of MDR-TB in Japan
Management of MDR-TB in Japan
Prof. An-Po Ambrose Chiang
Duke University School of Medicine
The use of PPG-based type 4 HSAT devices in screening and diagnosis of OSA: Is it ready for prime time?
South Western Sydney Clinical School
The role of treatment of LTBI in ending TB in high burden settings
Asthma airway remodeling
TMU’s “A-Team”, Working Together to Unravel the Mystery of Asthma. Asthma is responsible for reduced quality of life for around 400 million people worldwide. Fighting this respiratory disease is TMU’s “A-Team” – a group of top researchers brought together and led by TMU’s School of Respiratory Therapy Dr. Bing-Chang Chen.
In their multi-fronted attack on asthma, Dr. Chen’s expert team is probing the underlying molecular mechanisms of inflammation and airway fibrosis, neurophysiological and autoimmune signaling pathways, and stem cell therapies.
COPD airway remodeling
Open your window in just about any busy city in the world and take a deep breath. That is, if you dare risking the coughing, congestion, and inflammation that comes from a lungful of urban pollution. While these symptoms are a nuisance for healthy people, for patients suffering from chronic or serious lung disease, the matter could be one of life and death. But at least you can retreat to your home to enjoy the clean air, right? According to work done by Dr. Pai-Chien Chou, Taipei Medical University Hospital’s new Director of Thoracic Medicine and his team, your home might not have less air pollution that the bustling streets outside. Dr. Chou’s cutting edge work combining advances in medication, rehabilitation, and technology should help provide a solution.
The severity of sleep apnea has traditionally been measured in sleep labs, but the accuracy of these in-hospital measurements has been brought into question by recent research by thoracic and sleep medicine expert Dr. Wen-Te Liu. Dr. Liu, also an expert in artificial intelligence, is now working to integrate sleep science with IoT connected devices, cloud-based AI processing, physical and environmental sensing, and a large patient database, to build a comprehensive system for monitoring, predicting, and treating sleep disorders. The system is made possible by technological and processing advances, and is set to move monitoring and treatment of sleep disorders out of the hospital and into the home – a paradigm shift that will streamline doctors’ workflow and improve patient outcomes.
Looking at the big picture is something Dr. Chen-Yuan Chiang is better equipped for than most. He’s an expert in thoracic medicine who has studied psychiatry, and public policy. He spends half of his time traveling the world to help cure multiple drug resistant tuberculosis and half at Wanfang Hospital and Taipei Medical University. Able to navigate international health organizations as well as he can the internal workings of the chest cavity, Dr. Chiang is helping to significantly reduce the prevalence of mdrtb around the world through a holistic approach to treatment and care.